Vaccines and Autism: What You Should Know | Vaccine Education
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Values, Justifications, and Perspectives Connected to the Anti-Vaccination Movement Gigi Garzio [email protected]
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Sound Ideas University of Puget Sound Sound Ideas Summer Research Summer 2018 Values, Justifications, and Perspectives Connected to the Anti-Vaccination Movement Gigi Garzio [email protected] Follow this and additional works at: https://soundideas.pugetsound.edu/summer_research Part of the Anthropology Commons, and the Medicine and Health Commons Recommended Citation Garzio, Gigi, "Values, Justifications, and Perspectives Connected to the Anti-Vaccination Movement" (2018). Summer Research. 309. https://soundideas.pugetsound.edu/summer_research/309 This Article is brought to you for free and open access by Sound Ideas. It has been accepted for inclusion in Summer Research by an authorized administrator of Sound Ideas. For more information, please contact [email protected]. Introduction Throughout the 18th and 19th centuries, when the first smallpox outbreak began and the first vaccine was introduced, there has been vaccine skepticism (Offit, 2015). Smallpox outbreaks, and the fatalities that come with it, continued to spread around the world despite the development of the vaccine. However, between the 1940s and the early 1970s, anti-vaccine sentiment declined due to “three trends: a boom in vaccine science, discovery, and manufacture; public awareness of widespread outbreaks of infectious diseases (measles, mumps, rubella, pertussis, polio, and others) and the desire to protect children from these highly prevalent ills; and a baby boom, accompanied by increasing levels of education and wealth” (Poland et al, 2011). These factors led to general public acceptance of vaccines, which resulted in significant decreases in disease outbreaks. However, with less visible outbreaks of disease and more vaccines being added to the childhood vaccination schedule, the presence of the anti-vaccination movement returned in the 1970s (Wolfe, 2002). -
(MMRV) Vaccine
Addendum to MMR Vaccine (Measles, Mumps, Rubella, and Varicella): What You Need to Know Vaccine Information Statement 1. I agree that the person named below will get the vaccine checked below. 2. I received or was offered a copy of the Vaccine Information Statement (VIS) for the vaccine listed above. 3. I know the risks of the disease this vaccine prevents. 4. I know the benefits and risks of the vaccine. 5. I have had a chance to ask questions about the disease the vaccine prevents, the vaccine, and how the vaccine is given. 6. I know that the person named below will have the vaccine put in his/her body to prevent the disease this vaccine prevents. 7. I am an adult who can legally consent for the person named below to get the vaccine. I freely and voluntarily give my signed permission for this vaccine. Vaccine to be given: Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Information about person to receive vaccine (Please print) Name: Last First Middle Initial Birthdate Sex (mm/dd/yy) (circle one) M F Address: Street City County State Zip TX Signature of person to receive vaccine or person authorized to make the request (parent or guardian): x Date: x Date: Witness PRIVACY NOTIFICATION - With few exceptions, you have the right to request and be informed about information that the State of Texas collects about you. You are entitled to receive and review the information upon request. You also have the right to ask the state agency to correct any information that is determined to be incorrect. -
Mmrv Vaccine
VACCINE INFORMATION STATEMENT (Measles, Mumps, Many Vaccine Information Statements are available in Spanish and other languages. MMRV Vaccine Rubella and See www.immunize.org/vis Varicella) Hojas de información sobre vacunas están disponibles en español y en muchos otros What You Need to Know idiomas. Visite www.immunize.org/vis These are recommended ages. But children can get the Measles, Mumps, Rubella and second dose up through 12 years as long as it is at least 1 Varicella 3 months after the first dose. Measles, Mumps, Rubella, and Varicella (chickenpox) can be serious diseases: Children may also get these vaccines as 2 separate shots: MMR (measles, mumps and rubella) and Measles varicella vaccines. • Causes rash, cough, runny nose, eye irritation, fever. • Can lead to ear infection, pneumonia, seizures, brain 1 Shot (MMRV) or 2 Shots (MMR & Varicella)? damage, and death. • Both options give the same protection. Mumps • One less shot with MMRV. • Causes fever, headache, swollen glands. • Children who got the first dose as MMRV have • Can lead to deafness, meningitis (infection of the brain had more fevers and fever-related seizures (about and spinal cord covering), infection of the pancreas, 1 in 1,250) than children who got the first dose as painful swelling of the testicles or ovaries, and, rarely, separate shots of MMR and varicella vaccines on death. the same day (about 1 in 2,500). Rubella (German Measles) Your doctor can give you more information, • Causes rash and mild fever; and can cause arthritis, including the Vaccine Information Statements for (mostly in women). MMR and Varicella vaccines. -
Science Reporting Syllabus: Covering the Environment, Technology and Medicine
1 Science reporting syllabus: Covering the environment, technology and medicine Science reporting is in a moment of extreme transition: Popular science writing is experiencing a renaissance at precisely the moment that traditional media outlets are jettisoning specialized reporters. This creates tremendous opportunity and tremendous challenges. This course makes sure students are prepared to meet those challenges. Course objective This course is designed to acquaint reporters with all aspects of science reporting and writing. It will train participants to view new breakthroughs and discoveries with skepticism and will give students a working knowledge of many of the main areas of science coverage, including the environment, artificial intelligence, and human interaction with technology. There will be lessons on social media, online writing, news and feature writing, and writing long-form narratives. Learning objectives The syllabus is designed to strengthen students’ core competencies in several areas: Determining what sources and outlets can be trusted to discuss controversial or unproven claims. Learning which questions will elicit meaningful responses. Understanding that choosing not to cover a story can be just as important an editorial decision as deciding how to cover it. Evaluating what type of form a journalist is most comfortable with and seeking out ways to work in that form. Course design This course will focus on developing toolkits for evaluating science stories in addition to learning about some specific issues or controversies. It is designed as a workshop course for between 10 and 15 students. An integral part of the course is analyzing and critiquing other students’ work. Readings Required books Deborah Blum, Mary Knudson and Robin Marantz Henig, editors, A Field Guide for Science Writers, 2005. -
NIH FOIA Log - FY 2017
NIH FOIA Log - FY 2017 Date Request Id Organization Name City State Records Requested Received 45612 LSU Health - Shreveport Shreveport Louisiana Copies of 3 NIDDK grants. 10/3/2016 Records relating to the use of the investigational drug Fostriecin in a human clinical trial sponsored by the NCI's Cancer Therapy Evaluation 45614 Individual Lakeway Texas Program. 10/3/2016 Site visit reports for UTMB (3/1/15- present); Battelle-Ohio (10/1/15- present); and Alpha Genesis-SC 45615 SAEN Milford Ohio (4/1/14-present). 10/3/2016 A copy of NCI grant 1R43CA135915- 45616 UCLA School of Engineering Los Angeles California 01. 10/4/2016 Washington University School of A copy of NIAID grant 45617 Medicine St. Louis Missouri K22AI052407. 10/4/2016 Washington University School of A copy of NHLBI grant 45618 Medicine St. Louis Missouri R01HL081398. 10/4/2016 Grant application and summary Washington University School of statement for NIDDK grant 45619 Medicine St. Louis Missouri K01DK077878. 10/4/2016 Data pertaining to all NIH purchases of the Victor model plate reader (model Victor 1, 2, 3 and Victor X) 45620 IMGEN Technologies Alexandria Virginia from Perkin Elmer from 1999-2012. 10/3/2016 Copy of NEI grant R21EY026438- 45621 Tufts Medical Center Brookline Massachusetts 01. 10/5/2016 A copy of all emails to and from two NIH employees from May 25, 2016 to June 25, 2016 regarding the NTP 45622 Individual Greenbelt Maryland radiofrequency study. 10/5/2016 Date Request Id Organization Name City State Records Requested Received Copies of the RCDC Thesaurus from 45623 Catenion Berlin Other 2010-2014. -
Hearing Before the Committee on Government Reform
DOCUMENT RESUME ED 466 915 EC 309 063 TITLE Autism: Present Challenges, Future Needs--Why the Increased Rates? Hearing before the Committee on Government Reform. House of Representatives, One Hundred Sixth Congress, Second Session (April 6,2000). INSTITUTION Congress of the U.S., Washington, DC. House Committee on Government Reform. REPORT NO House-Hrg-106-180 PUB DATE 2001-00-00 NOTE 483p. AVAILABLE FROM Government Printing Office, Superintendent of Documents, Congressional Sales Office, Washington, DC 20402-9328. Tel: 202-512-1800. For full text: http://www.house.gov/reform. PUB TYPE Legal/Legislative/Regulatory Materials (090) EDRS PRICE EDRS Price MF02/PC20 Plus Postage. DESCRIPTORS *Autism; *Child Health; Children; *Disease Control; *Etiology; Family Problems; Hearings; *Immunization Programs; Incidence; Influences; Parent Attitudes; *Preventive Medicine; Research Needs; Symptoms (Individual Disorders) IDENTIFIERS Congress 106th; Vaccination ABSTRACT This document contains the proceedings of a hearing on April 6, 2000, before the U.S. House of Representatives Committee on Government Reform. The hearing addressed the increasing rate of children diagnosed with autism, possible links between autism and childhood vaccinations, and future needs of these children. After opening statements by congressmen on the Committee, the statements and testimony of Kenneth Curtis, James Smythe, Shelley Reynolds, Jeana Smith, Scott Bono, and Dr. Wayne M. Danker, all parents of children with autism, are included. Their statements discuss symptoms of autism, vaccination concerns, family problems, financial concerns, and how parents can be helped. The statements and testimony of the second panel are then provided, including that of Andrew Wakefield, John O'Leary, Vijendra K. Singh, Coleen A. Boyle, Ben Schwartz, Paul A. -
Vaccine Information for PARENTS and CAREGIVERS
NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES Division of the National Health Laboratory Service VACCINE INFOR MATION FOR PARENTS & CAREGIVERS First Edition November 2016 Editors-in-Chief Nkengafac Villyen Motaze (MD, MSc, PhD fellow), Melinda Suchard (MBBCh, FCPath (SA), MMed) Edited by: Cheryl Cohen, (MBBCh, FCPath (SA) Micro, DTM&H, MSc (Epi), Phd) Lee Baker, (Dip Pharm) Lucille Blumberg, (MBBCh, MMed (Micro) ID (SA) FFTM (RCPS, Glasgow) DTM&H DOH DCH) Published by: Ideas Wise and Wonderful (IWW) for National Institute for Communicable Diseases (NICD) First Edition: Copyright © 2016 Contributions by: Clement Adu-Gyamfi (BSc Hons, MSc), Jayendrie Thaver (BSc), Kerrigan McCarthy, (MBBCh, FCPath (SA), DTM&H, MPhil (Theol) Kirsten Redman (BSc Hons), Nishi Prabdial-Sing (PhD), Nonhlanhla Mbenenge (MBBCh, MMED) Philippa Hime (midwife), Vania Duxbury (BSc Hons), Wayne Howard (BSc Hons) Acknowledgments: Amayeza, Vaccine Information Centre (http://www.amayeza-info.co.za/) Centre for Communicable Diseases Fact Sheets (http://www.cdc.gov/vaccines/hcp/vis/) World Health Organization Fact Sheets (http://www.who.int/mediacentre/factsheets/en/) National Department of Health, South Africa (http://www.health.gov.za/) Disclaimer This book is intended as an educational tool only. Information may be subject to change as schedules or formulations are updated. Summarized and simplified information is presented in this booklet. For full prescribing information and contraindications for vaccinations, please consult individual package inserts. There has been -
Electronic Support for Public Health–Vaccine Adverse Event Reporting System (ESP:VAERS)
Grant Final Report Grant ID: R18 HS 017045 Electronic Support for Public Health–Vaccine Adverse Event Reporting System (ESP:VAERS) Inclusive dates: 12/01/07 - 09/30/10 Principal Investigator: Lazarus, Ross, MBBS, MPH, MMed, GDCompSci Team members: Michael Klompas, MD, MPH Performing Organization: Harvard Pilgrim Health Care, Inc. Project Officer: Steve Bernstein Submitted to: The Agency for Healthcare Research and Quality (AHRQ) U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Abstract Purpose: To develop and disseminate HIT evidence and evidence-based tools to improve healthcare decision making through the use of integrated data and knowledge management. Scope: To create a generalizable system to facilitate detection and clinician reporting of vaccine adverse events, in order to improve the safety of national vaccination programs. Methods: Electronic medical records available from all ambulatory care encounters in a large multi-specialty practice were used. Every patient receiving a vaccine was automatically identified, and for the next 30 days, their health care diagnostic codes, laboratory tests, and medication prescriptions were evaluated for values suggestive of an adverse event. Results: Restructuring at CDC and consequent delays in terms of decision making have made it challenging despite best efforts to move forward with discussions regarding the evaluation of ESP:VAERS performance in a randomized trial and comparison of ESP:VAERS performance to existing VAERS and Vaccine Safety Datalink data. However, Preliminary data were collected and analyzed and this initiative has been presented at a number of national symposia. Key Words: electronic health records, vaccinations, adverse event reporting The authors of this report are responsible for its content. -
Combination Vaccines
INFORMATION FOR PARENTS Combination Vaccines Last updated April 2014 The measles, mumps, and rubella vaccine (MMR) and Combination vaccines reduce the diphtheria, tetanus, and pertussis vaccine (DTaP) each protect your child against three diseases. However, these number of shots your child needs two vaccines are not considered true combination vaccines while protecting against several because in the United States, you cannot get separate serious diseases. vaccines for all of the diseases that MMR and DTaP protect against. Fewer Shots—Same Protection Some examples of common combination vaccines for children are: Combination vaccines take two or more vaccines that could be given individually and put them into one • Comvax, which combines Hib and Hep B shot. Children get the same protection as they do from • Twinrix, which combines Hep A and Hep B individual vaccines given separately—but with fewer shots. • Pediarix, which combines DTaP, Hep B, and IPV (polio) So, at a doctor’s visit, your child may only get two or three shots to protect him from five diseases, instead of five • ProQuad, which combines MMR and individual shots. Fewer shots may mean less pain for your varicella (chickenpox) child and less stress for you. • Kinrix, which combines DTaP and IPV (polio) • Pentacel, which combines DTaP, IPV (polio), and Hib To learn about the diseases that vaccines prevent, visit: http://www.cdc.gov/vaccines/vpd-vac/fact-sheet-parents.html Fewer Shots—On Time Protection Combination vaccines help parents, doctors, and nurses keep children up-to-date on vaccines. Combining vaccines into fewer shots may mean that more children will get recommended vaccinations on time. -
AAP Immunizations Frequently Asked Questions: Vaccine Safety
AAP Immunizations Frequently Asked Questions: Vaccine Safety As a parent, you might have questions and concerns about vaccine safety. With so much incorrect information on the Internet and in the media, it is often hard to find trustworthy, clear, and up-to-date information. The truth is that today’s vaccines are the most effective and safest in history and have protected and saved millions of lives from vaccine-preventable diseases. However, some children are too young or too sick to receive vaccines. And some children do have side effects. Listed below are common questions about vaccine safety and the AAP’s response. How are vaccines licensed and monitored to ensure their safety? The Food and Drug Administration (FDA) tests new vaccines for up to 10 years before issuing the vaccine a license. All vaccines must be safe and proven to work well in children. Once the vaccine is being used, the FDA and the Centers for Disease Control and Prevention (CDC) monitor it through the Vaccine Adverse Event Reporting System (VAERS). Researchers look for any problem with a vaccine, inspect the problem, and decide what to do. When VAERS found a problem in the past, changes included: • Using different labels or packaging, • Sending safety alerts, • Inspecting manufacturers' records, and • Taking away the vaccine's license. For more information about VAERS, visit http://vaers.hhs.gov/index or call the toll-free VAERS information line at 1-800-822-7967. For more information about licensing vaccines, visit http://www.aap.org/immunization/families/VaccineSafety_parenthandout.pdf The Vaccine Safety Datalink (VSD) is a collaborative effort between the Centers for Disease Control and Prevention and 9 managed care organizations (MCOs) in the United States. -
Biotechnology and Consumer Decision-Making
SAX (DO NOT DELETE) 2/16/2017 2:44 PM Biotechnology and Consumer Decision-Making Joanna K. Sax* ABSTRACT Society is facing major challenges in climate change, health care and overall quality of life. Scientific advances to address these areas continue to grow, with overwhelming evidence that the application of highly tested forms of biotechnology is safe and effective. Despite scientific consensus in these areas, consumers appear reluctant to support their use. Research that helps to understand consumer decision-making and the public’s resistance to biotechnologies such as vaccines, fluoridated water programs and genetically engineered food, will provide great social value. This article is forward-thinking in that it suggests that important research in behavioral decision-making, specifically affect and ambiguity, can be used to help consumers make informed choices about major applications of biotechnology. This article highlights some of the most controversial examples: vaccinations, genetically engineered food, rbST treated dairy cows, fluoridated water, and embryonic stem cell research. In many of these areas, consumers perceive the risks as high, but the experts calculate the risks as low. Four major thematic approaches are proposed to create a roadmap for policymakers to consider for policy design and implementation in controversial areas of biotechnology. This article articulates future directions for studies that implement decision-making research to allow consumers to appropriately assign risk to their options and make informed decisions. * Visiting Faculty Member, James E. Rogers College of Law – University of Arizona (Fall 2016); Professor of Law, California Western School of Law; J.D., University of Pennsylvania Law School; Ph.D., University of Pennsylvania School of Medicine. -
COVID-19 Vaccinations with an Update from 12/16/2020
COVID-19 Vaccinations with an Update from 12/16/2020 Michael A. Kaufmann, MD, FACEP, FAEMS State EMS Medical Director Indiana Department of Homeland Security Hot Off The Press • 12/11/2020 • Vaccine advisers to the US Food and Drug Administration voted Thursday to recommend the agency grant emergency use authorization to Pfizer and BioNTech's coronavirus vaccine. • Seventeen members of the Vaccines and Related Biological Products Advisory Committee voted yes, four voted no and one abstained. • "The question is never when you know everything. It's when you know enough and I think we know enough now to say that this appears to be our way out of this awful, awful mess," Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia and a member of the committee, told CNN's Wolf Blitzer after the vote. • "That's why I voted yes." FDA Concerns • Several committee members expressed concern about reports of allergic reactions in two people who were vaccinated in Britain, which authorized Pfizer's vaccine ahead of the US. • FDA staff said that, as with any vaccines, paperwork would accompany the Pfizer vaccine to warn against administering it to anyone with a history of severe allergic reactions to vaccines or allergies to any of the ingredients of the vaccine. • The FDA will now decide whether to accept the recommendation, but has signaled that it will issue the EUA for the vaccine. • ACIP has a meeting scheduled for Friday, and expects to vote during a meeting scheduled for Sunday. • Operation Warp Speed officials say they will start shipping the vaccine within 24 hours of FDA authorization.